Related Experiment Video
Updated: Jun 10, 2025
05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
1.1K
2D MXene Nanosheets with ROS Scavenging Ability Effectively Delay Osteoarthritis Progression
Hongqi Zhao1, Tianqi Wang1, Xuan Fang1
1Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Nanomaterials (Basel, Switzerland)
|October 15, 2024
Summary
Titanium carbide (Ti3C2Tx) MXene nanosheets show promise for osteoarthritis treatment by scavenging reactive oxygen species and reducing inflammation. In vitro and in vivo studies confirm their potential to protect cartilage and slow disease progression.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Orthopedics
Background:
- Osteoarthritis (OA) is a degenerative joint disease linked to oxidative stress.
- Reactive oxygen species (ROS) play a key role in OA pathogenesis.
- Current OA treatments have limitations in addressing underlying disease mechanisms.
Purpose of the Study:
- To investigate the therapeutic potential of Ti3C2Tx MXene nanosheets for osteoarthritis.
- To evaluate the efficacy of Ti3C2Tx nanosheets in mitigating oxidative stress and inflammation in OA.
- To explore the underlying mechanisms of Ti3C2Tx nanosheet action in OA.
Main Methods:
- In vitro studies using chondrocytes exposed to oxidative stress.
- RNA sequencing to elucidate molecular mechanisms.
- In vivo validation using a rat model of osteoarthritis.
- Histological and immunohistochemical analyses of joint tissues.
Main Results:
- Ti3C2Tx nanosheets demonstrated potent ROS scavenging ability and biocompatibility.
- Nanosheets protected chondrocytes from oxidative stress-induced death.
- Ti3C2Tx exhibited anti-inflammatory effects and restored chondrocyte anabolic-catabolic balance.
- In vivo studies showed significant amelioration of OA progression in rats treated with Ti3C2Tx.
Conclusions:
- Ti3C2Tx MXene nanosheets offer a promising therapeutic strategy for osteoarthritis.
- The ROS scavenging and anti-inflammatory properties are key to their efficacy.
- Further research into MXene-based therapies for degenerative diseases is warranted.
